Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives).
D000818:Animals; D053961:Azabicyclo Compounds; D001569:Benzodiazepines / Q000378:metabolism*; D001667:Binding, Competitive; D002525:Cerebellar Cortex / Q000187:drug effects / Q000378:metabolism; D002707:Chlordiazepoxide / Q000494:pharmacology; D003220:Conflict, Psychological / Q000187:drug effects*; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D003975:Diazepam / Q000378:metabolism; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology; D011804:Quinolines / Q000378:metabolism*; D051381:Rats; D011955:Receptors, Drug / Q000378:metabolism*; D011963:Receptors, GABA-A
D053961:Azabicyclo Compounds; D006993:Hypnotics and Sedatives; D010879:Piperazines; D011804:Quinolines; D011955:Receptors, Drug; D011963:Receptors, GABA-A; C515050:zopiclone; D001569:Benzodiazepines; D002707:Chlordiazepoxide; C030079:PK 9084; D000242:Cyclic AMP; D006152:Cyclic GMP; C030078:pipequaline; D003975:Diazepam